Pain duration (mean pain duration, assessed at 4 weeks) · Children with recurrent abdominal pain
It is very uncertain whether antispasmodics changes pain duration (mean pain duration, assessed at 4 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Pain improvement (clinician judged, assessed at 2 weeks) · Children with recurrent abdominal pain
It is very uncertain whether antispasmodics changes pain improvement (clinician judged, assessed at 2 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Pain episodes · Children with recurrent abdominal pain
It is very uncertain whether antispasmodics changes pain frequency (episodes of pain in 4 weeks, assessed after 4 weeks) compared with placebo (very low certainty).
1 finding from 1 review
Pain improvement (self reported response to treatment, assessed at 4 weeks) · Children with recurrent abdominal pain
Antispasmodics showed no clear difference in pain improvement (self reported response to treatment, assessed at 4… compared with placebo (low certainty).
1 finding from 1 review
Activity Gross motor function · children and adolescents with cerebral palsy
1 finding from 1 review
Activity Gait speed · children and adolescents with cerebral palsy
1 finding from 1 review
Activity Gross motor function · children and adolescents with cerebral palsy
2 findings from 1 review
Activity Gait speed · children and adolescents with cerebral palsy
2 findings from 1 review
Participation · children and adolescents with cerebral palsy
1 finding from 1 review
Activity Gross motor function · children and adolescents with cerebral palsy
1 finding from 1 review
Activity Gross motor function · children with cerebral palsy
1 finding from 1 review
Cognitive abilities (Severe Impairment Battery; SIB) · people with Down syndrome
1 finding from 1 review
Carer stress · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Institutional/home care · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Behavioural problems: overall · people with Down syndrome
1 finding from 1 review
Adverse events · people with Down syndrome
Comparison 1: donepezil may leads to lower adverse events compared with placebo (low certainty).
1 finding from 1 review
Carer stress · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Institutional/home care · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · people with Down syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found